About
Anthony P. Mack is a biopharma executive, founder, and CEO with experience building and scaling therapeutic platforms and assets across early development, capital formation, governance, and strategic transactions. He is President & CEO of Pathways Neuro Pharma, a gene therapy company advancing genetically validated, CNS-targeted therapies for young-onset and rare neurodegenerative diseases, with an initial focus on Parkinson’s disease. Across prior ventures — including leadership roles at Virpax Pharmaceuticals, Scilex Pharmaceuticals, and ProSolus — he has led organizations through early clinical development, financings, public markets, and strategic transactions. Collectively, he has overseen deployment of over $100M in capital across clinical, CMC, and commercialization milestones. His background spans platform and asset development, regulatory strategy, capital markets (Series 7 & 24), governance leadership, and transaction execution across private and public life sciences compa
Position in the VCSift Database
- • 1,305 investors hold the Chief Executive Officer role in VCSift. Anthony P Mack is one of them.
- • 2,799 investors are based in United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Contact Information
Find more investors like Anthony P
Search Investors